Head-to-head · Cost-Efficiency Index
TeleHealth Med vs Kin Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
TeleHealth Med
Shoppers willing to run the intake selector before seeing a price — public pricing isn't published.
Visit TeleHealth MedKin Meds
Shoppers modeling the real monthly cost before they commit.
Visit Kin MedsThe verdict
TeleHealth Med takes it, leading the Cost-Efficiency Index 48 to 47. TeleHealth Med, Inc. is a Georgia-incorporated telehealth weight-loss platform offering compounded semaglutide and tirzepatide in injectable and sublingual forms. Kin Meds still earns a C — Shoppers modeling the real monthly cost before they commit.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs TeleHealth Med.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | TeleHealth Med | Kin Meds |
|---|---|---|
| Cost-Efficiency Index | 48/100 | 47/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #443 | #447 |
TeleHealth Med
48/100Where the value is
- Publishes the FDA compounded-medication disclaimer and displays a LegitScript verification badge with a working verification link
- Offers both injectable and sublingual (oral) forms of compounded GLP-1 — a real formulation choice most competitors don't have
- Georgia corporate entity (TeleHealth Med, Inc.) is named, giving clearer legal accountability
The tradeoffs
- No dollar figure appears anywhere on the public homepage or any subpage reached — pricing is generated only after completing an in-funnel medication/state selector
- The site returns HTTP 403 to plain automated requests, making it unusually hard to verify pricing
Kin Meds
47/100Where the value is
- Appears to have an established web/social presence per search results
The tradeoffs
- Site is unreachable for independent verification behind active bot/CAPTCHA protection
- No pricing, medical director, or pharmacy partner could be confirmed directly from the company
Regulatory note: the FDA issued a warning letter to Kin Meds in February 2026. We still list and link to Kin Meds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.